Intel Capital And Khosla Ventures Lead $27M Investment In Siphox® Health To Transform Health Testing
Intel Capital And Khosla Ventures Lead $27M Investment In Siphox® Health To Transform Health Testing
07/19/23, 1:08 PM
Location
burlingtonMoney raised
$27 million
Industry
information technology
Investors
Intel Capital Managing Director Srini Ananth, Longevity Tech Fund, Bob Lee, Balaji Srinivasan, Paul Buchheit, Vituity, Rsquared, Massachusetts Manufacturing Innovation Initiative, Y Combinator, Duke Capital Partners, Overlap Holdings, Longe Vc, Shorewind Capital, Metaplanet, Alumni Ventures, Kortex Ventures, Khosla Ventures, Intel Capital
SiPhox Health, the leader in building the next generation of lab-grade home health testing with silicon photonics, raised $27 million in funding including a $10M Seed financing and a $17M Series A round. The Series A round was led by Intel Capital with participation from Khosla Ventures, Kortex Ventures, Alumni Ventures, Metaplanet, Shorewind Capital, LongeVC, Overlap Holdings and Duke Capital Partners. The Seed funding was led by Khosla Ventures and Y Combinator with participation from Metaplanet, Massachusetts Manufacturing Innovation Initiative, Rsquared, Vituity, Paul Buchheit, Balaji Srinivasan, Bob Lee, and Longevity Tech Fund among others. Intel Capital managing director Srini Ananth will also join SiPhox Health’s board of directors to further accelerate the company’s growth.
Company Info
Location
111 terrace hall ave.
burlington, vermont, united states
Additional Info
SiPhox was founded by Diedrik Vermeulen and Michael Dubrovsky one month BC (before Covid) in 2020. SiPhox’s mission is to build a next-generation biosensing platform that provides the power of several large laboratory instruments in a handheld device that accepts disposable cartridges. Each cartridge can multiplex many biomarkers on a single $0.50 silicon photonic chip and provides highly sensitive readout of immunoassays and RNA/DNA.
The SiPhox team has extensive experience translating cutting-edge optical chip technology into mass produced products used all over the world, and is bringing the same proven approach to the next frontier for integrated photonics: biology.